"10.1371_journal.pone.0150085","plos one","2016-02-24T00:00:00Z","Nanditha Mohan Das; Sarah Hatsell; Kalyan Nannuru; Lily Huang; Xialing Wen; Lili Wang; Li-Hsien Wang; Vincent Idone; Jeffrey A Meganck; Andrew Murphy; Aris Economides; LiQin Xie","Department of Skeletal Diseases â€ Therapeutic Focus Areas, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States of America; Research and Development, PerkinElmer, Hopkinton, Massachusetts, United States of America","Conceived and designed the experiments: LX AE SH LHW KN VI AM. Performed the experiments: LX XW LH LW KN. Analyzed the data: LX ND JAM KN SH. Contributed reagents/materials/analysis tools: LX ND JAM SH. Wrote the paper: ND LX AE JAM.","This study received internal funding from Regeneron Pharmaceuticals Inc. LiQin Xie, Nanditha Mohan Das, Sarah Hatsell, Kalyan Nannuru, Lily Huang, Xialing Wen, Lili Wang, Li-Hsien Wang, Vincent Idone, Andrew Murphy, and Aris Economides are employed by Regeneron Pharmaceuticals Inc. Jeffrey A. Meganck is employed by PerkinElmer. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Nanditha Mohan Das","NMD",12,TRUE,7,5,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
